Skip to main content
BIO logo
BIO
(NYSE)
Bio-Rad Laboratories, Inc.
$287.86-- (--)
Loading... - Market loading

Bio-Rad Laboratories (BIO) Stock Price & Financial Analysis

Bio-Rad Laboratories Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$275.08 - $288.56
52-Week High$343.12
52-Week Low$211.43
Open$282.58
Volume545.43K
Average Volume (3M)378.10K
Market Cap7.60B
Shares Outstanding26.96M
P/E Ratio (TTM)39.53
Price to Sales (P/S)2.58
Price to Book (P/B)0.97
EV/EBITDA12.71
Revenue (TTM)2.59B
Net Income (TTM)168.80M
Free Cash Flow (TTM)357.20M
EPS (TTM)$6.24
Profit Margin6.52%
Operating Margin9.10%
Return on Equity (ROE)2.46%
Debt to Equity0.18
50-Day MA$274.51
200-Day MA$292.35
52-Week Change-5.02%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Bio-Rad Laboratories

What is the current stock price for BIO?

As of the latest trading session, BIO stock trades at $287.86. The 52-week range is $211.43–$343.12, with a day range of $275.08–$288.56.

What is the P/E ratio for BIO?

Bio-Rad Laboratories's trailing P/E ratio is 39.5, meaning investors pay $39.5 for every $1 of annual earnings.

Does BIO pay dividends?

Bio-Rad Laboratories does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BIO?

Based on 1 analyst, the consensus for BIO is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BIO?

Bio-Rad Laboratories's market capitalization is $7.76B, classifying it as a mid-cap company..